Department of Medicine, Mount Sinai Morningside and Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Division of Hospital Medicine, Department of Medicine, Mount Sinai Morningside and Mount Sinai West, Icahn School of Medicine at Mount Sinai, 1000 10th Ave, New York, NY, 10019, USA.
BMC Prim Care. 2022 Mar 3;23(1):38. doi: 10.1186/s12875-022-01651-9.
Mounting evidence suggests the safety and efficacy of medical marijuana (MM) in treating chronic ailments, including chronic pain, epilepsy, and anorexia. Despite incremental use of medical and recreational cannabinoids, current limited evidence shows generalized unpreparedness of medical providers to discuss or recommend these substances to their patients. Herein, the present study aims to examine internal medicine residents' knowledge of marijuana and their attitude towards its medical use.
This is a descriptive cross-sectional study. A survey with 12 standardized queries was created and distributed among the internal medicine residents from Mount Sinai Morningside-West (MSMW) program from July 2020 to December 2020. Participants included preliminary and categorical residents from post-graduate years one to three. The survey consisted of self-assessment of residents' knowledge on the indication, contraindication, adverse effects of MM.
Eighty-six (59%) out of 145 residents completed the questionnaire. Despite most trainees (70%) having considered certifying the use of MM for their patients, over 90% reported none to little knowledge on its use. Approximately 80% of the surveyed residents expressed willingness to receive an appropriate educational curriculum.
To the best of our knowledge, this is the first study that indicated a critical lack of medical marijuana-related knowledge in surveyed internal medicine residents. In a population with growing cannabis consumption, physician training on the indication, toxicity, and drug interaction of cannabinoids is warranted.
越来越多的证据表明医用大麻（MM）在治疗慢性疾病方面的安全性和有效性，包括慢性疼痛、癫痫和厌食症。尽管医用和娱乐用大麻素的使用在逐渐增加，但目前有限的证据表明，医疗服务提供者普遍对讨论或向患者推荐这些物质准备不足。在此，本研究旨在调查内科住院医师对大麻的认识及其对其医疗用途的态度。
这是一项描述性的横断面研究。我们创建了一个包含 12 个标准化问题的调查，并于 2020 年 7 月至 2020 年 12 月期间分发给西奈山芒特西奈医院（MSMW）项目的内科住院医师。参与者包括从住院医师第一年到第三年的初级和分类住院医师。该调查包括住院医师对 MM 的适应证、禁忌证、不良反应的自我评估知识。
在 145 名住院医师中，有 86 名（59%）完成了问卷。尽管大多数受训者（70%）曾考虑为他们的患者开具 MM 的使用证明，但超过 90%的人报告说对其使用知之甚少。大约 80%的接受调查的住院医师表示愿意接受适当的教育课程。
据我们所知，这是第一项表明接受调查的内科住院医师对医用大麻相关知识严重缺乏的研究。在大麻消费不断增长的人群中，有必要对医生进行关于大麻素的适应证、毒性和药物相互作用的培训。
